Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]

Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC] was reported 16195 times

Drugs of the Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 TOOTH INJURY 1990 0.4579
1 SKELETAL INJURY 3848 0.3717
2 BONE DEMINERALISATION 281 0.2653
3 BONE LOSS 3658 0.2431
4 BONE DENSITY DECREASED 7270 0.2318
5 MULTIPLE FRACTURES 3303 0.2009
6 TOOTH LOSS 3790 0.1826
7 RENAL INJURY 4294 0.1444
8 BONE DENSITY ABNORMAL 451 0.1206
9 OSTEOPENIA 1821 0.1199
10 OSTEONECROSIS 3595 0.1093
11 PROTEIN TOTAL ABNORMAL 140 0.1075
12 ANHEDONIA 2517 0.0957
13 DEGENERATIVE BONE DISEASE 42 0.0948
14 HIV-ASSOCIATED NEUROCOGNITIVE DISORDER 10 0.0901
15 HIV ASSOCIATED NEPHROPATHY 4 0.0784
16 TESTICULAR OPERATION 4 0.0714
17 OSTEOPOROSIS 2920 0.0709
18 ECONOMIC PROBLEM 1039 0.0685
19 PAST-POINTING 3 0.0667
20 OSTEOMALACIA 101 0.0653
21 TEETH BRITTLE 68 0.0649
22 GLOMERULAR FILTRATION RATE ABNORMAL 88 0.0621
23 FEAR-RELATED AVOIDANCE OF ACTIVITIES 9 0.0592
24 CSF VIRUS IDENTIFIED 4 0.0571
25 VITAMIN D DEFICIENCY 539 0.0552
26 CHRONIC KIDNEY DISEASE 4186 0.0550
27 NEPHROPATHY 494 0.0529
28 FANCONI SYNDROME ACQUIRED 88 0.0501
29 DYSDIADOCHOKINESIS 8 0.0468
30 RENAL DYSPLASIA 18 0.0465
31 BLOOD HIV RNA INCREASED 84 0.0463
32 MENINGOENCEPHALITIS VIRAL 8 0.0452
33 HYPOTENSIVE CRISIS 6 0.0417
34 HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION 13 0.0362
35 MEDICAL DIET 7 0.0355
36 SOCIOECONOMIC PRECARITY 6 0.0349
37 GENOTYPE DRUG RESISTANCE TEST POSITIVE 35 0.0340
38 VIRAL LOAD INCREASED 128 0.0329
39 FAT REDISTRIBUTION 7 0.0302
40 VIRAL LOAD 5 0.0289
41 VIRAL LOAD ABNORMAL 5 0.0286
42 HAND FRACTURE 193 0.0272
43 LIMB FRACTURE 4 0.0267
44 FRACTURE 504 0.0266
45 PROTEIN TOTAL INCREASED 70 0.0263
46 RENAL FAILURE 3404 0.0256
47 TOOTH FRACTURE 274 0.0248
48 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 26 0.0245
49 AVULSION FRACTURE 7 0.0244
50 CENTRAL NERVOUS SYSTEM INFLAMMATION 8 0.0241
51 CD4 LYMPHOCYTES ABNORMAL 5 0.0238
52 EMOTIONAL DISTRESS 2845 0.0235
53 RENAL TUBULAR DYSFUNCTION 13 0.0230
54 GLOMERULAR FILTRATION RATE INCREASED 19 0.0230
55 GENE MUTATION IDENTIFICATION TEST POSITIVE 9 0.0214
56 CD4 LYMPHOCYTES DECREASED 45 0.0210
57 LIPOHYPERTROPHY 13 0.0209
58 SYPHILIS 14 0.0193
59 FIBULA FRACTURE 55 0.0191
60 FOOT FRACTURE 349 0.0184
61 VERTEBRAL FORAMINAL STENOSIS 15 0.0182
62 SINGLE FUNCTIONAL KIDNEY 12 0.0181
63 JAW FRACTURE 38 0.0176
64 FOREARM FRACTURE 12 0.0172
65 CD4 LYMPHOCYTES INCREASED 4 0.0172
66 RENAL APLASIA 12 0.0171
67 SCHIZOPHRENIFORM DISORDER 4 0.0165
68 NIPPLE SWELLING 4 0.0159
69 BONE DISORDER 289 0.0158
70 ANKLE FRACTURE 239 0.0154
71 PROTEIN S DEFICIENCY 3 0.0152
72 OSTEOPOROTIC FRACTURE 28 0.0146
73 WRIST FRACTURE 174 0.0145
74 INTERVERTEBRAL DISC DEGENERATION 133 0.0144
75 HIV VIRAEMIA 3 0.0143
76 ADRENAL SUPPRESSION 12 0.0142
77 TIBIA FRACTURE 66 0.0141
78 HIV TEST POSITIVE 9 0.0136
79 BLOOD CREATININE INCREASED 888 0.0136
80 ANOGENITAL WARTS 12 0.0135
81 SCAPULA FRACTURE 7 0.0134
82 FOETAL EXPOSURE DURING DELIVERY 9 0.0133
83 END STAGE RENAL DISEASE 236 0.0129
84 ACUTE HIV INFECTION 3 0.0121
85 RADIUS FRACTURE 29 0.0121
86 ENCEPHALOCELE 3 0.0120
87 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 13 0.0120
88 GLYCOSURIA 16 0.0118
89 GLUCOCORTICOID DEFICIENCY 5 0.0118
90 CLAVICLE FRACTURE 45 0.0117
91 ALBUMINURIA 6 0.0112
92 FACIAL WASTING 3 0.0112
93 GONORRHOEA 3 0.0111
94 ULNA FRACTURE 11 0.0111
95 BONE INFARCTION 5 0.0110
96 CHLAMYDIAL INFECTION 8 0.0106
97 OVARIAN NEOPLASM 8 0.0105
98 ENAMEL ANOMALY 3 0.0105
99 SPINAL STENOSIS 43 0.0104
100 LIPODYSTROPHY ACQUIRED 22 0.0104
101 VIRAL MUTATION IDENTIFIED 38 0.0103
102 FACIAL BONES FRACTURE 37 0.0103
103 POOR DENTAL CONDITION 3 0.0101
104 PRODUCT LABEL ON WRONG PRODUCT 4 0.0101
105 JOINT SPACE NARROWING 3 0.0101
106 BONE METABOLISM DISORDER 3 0.0100
107 RENAL IMPAIRMENT 838 0.0100
108 GLOMERULAR FILTRATION RATE DECREASED 122 0.0099
109 CREATININE URINE INCREASED 3 0.0099
110 SHOULDER FRACTURE 16 0.0098
111 FRACTURED SACRUM 12 0.0096
112 ACQUIRED IMMUNODEFICIENCY SYNDROME 5 0.0096
113 RIB FRACTURE 197 0.0096
114 PROTEINURIA 180 0.0095
115 SPINAL OSTEOARTHRITIS 83 0.0094
116 VERTEBRAL OSTEOPHYTE 4 0.0094
117 ANXIETY 2634 0.0092
118 DENTAL CARIES 102 0.0092
119 PERIPHERAL NERVE INJURY 8 0.0091
120 BONE DEFORMITY 6 0.0089
121 T-LYMPHOCYTE COUNT DECREASED 6 0.0088
122 MENINGITIS VIRAL 12 0.0087
123 HUMERUS FRACTURE 42 0.0087
124 FRACTURED COCCYX 11 0.0087
125 HIP ARTHROPLASTY 132 0.0086
126 FAT TISSUE INCREASED 12 0.0083
127 CERVICAL SPINAL STENOSIS 14 0.0081
128 QUALITY OF LIFE DECREASED 109 0.0081
129 SPONDYLOLISTHESIS 14 0.0081
130 LID SULCUS DEEPENED 3 0.0080
131 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 40 0.0080
132 RENAL ATROPHY 10 0.0080
133 VIRAEMIA 11 0.0079
134 FANCONI SYNDROME 11 0.0078
135 ANAEMIA OF CHRONIC DISEASE 7 0.0077
136 PATELLA FRACTURE 18 0.0077
137 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 5 0.0077
138 RENAL CYST 61 0.0077
139 GASTROINTESTINAL TUBE INSERTION 19 0.0076
140 BLOOD CREATININE ABNORMAL 26 0.0075
141 DECREASED ACTIVITY 81 0.0075
142 PATHOLOGICAL FRACTURE 38 0.0075
143 INTERVERTEBRAL DISC SPACE NARROWING 6 0.0074
144 PROTEIN URINE PRESENT 37 0.0074
145 LIPOATROPHY 7 0.0074
146 RENAL TUBULAR DISORDER 20 0.0071
147 GASTROSTOMY 11 0.0071
148 VIROLOGIC FAILURE 38 0.0071
149 SOFT TISSUE SWELLING 4 0.0070
150 CRANIOFACIAL FRACTURE 6 0.0070
151 CERVICAL RADICULOPATHY 5 0.0070
152 PRODUCT DIFFICULT TO SWALLOW 7 0.0069
153 HIP DEFORMITY 3 0.0069
154 OSTEOGENESIS IMPERFECTA 4 0.0069
155 SPINAL COMPRESSION FRACTURE 56 0.0068
156 RENAL TUBULAR INJURY 8 0.0066
157 SITTING DISABILITY 4 0.0065
158 UPPER LIMB FRACTURE 129 0.0065
159 BLOOD CREATINE INCREASED 28 0.0063
160 PARTNER STRESS 6 0.0063
161 OSTEOARTHRITIS 262 0.0062
162 ACUTE KIDNEY INJURY 944 0.0062
163 UNDERWEIGHT 12 0.0061
164 THORACIC VERTEBRAL FRACTURE 18 0.0061
165 CONGENITAL CYSTIC KIDNEY DISEASE 5 0.0059
166 HIV INFECTION 17 0.0056
167 JC VIRUS INFECTION 9 0.0056
168 LOWER LIMB FRACTURE 106 0.0055
169 SPINAL FRACTURE 110 0.0055
170 MULTIPLE-DRUG RESISTANCE 17 0.0055
171 COMPRESSION FRACTURE 29 0.0054
172 BONE FRAGMENTATION 3 0.0054
173 PARAINFLUENZAE VIRUS INFECTION 8 0.0053
174 CORTISOL DECREASED 6 0.0052
175 CHOREA 9 0.0052
176 OSTEOCHONDROSIS 6 0.0052
177 STRESS FRACTURE 27 0.0050
178 PERIODONTAL DISEASE 7 0.0050
179 GASTRECTOMY 5 0.0050
180 HYDROPS FOETALIS 3 0.0049
181 MYOPATHY TOXIC 3 0.0049
182 HIP FRACTURE 156 0.0048
183 RENAL TUBULAR NECROSIS 47 0.0048
184 PAIN 2923 0.0048
185 HEPATITIS A 4 0.0047
186 NECROTISING RETINITIS 3 0.0047
187 PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT 4 0.0046
188 SHOULDER ARTHROPLASTY 12 0.0045
189 PERIARTHRITIS 10 0.0044
190 LUMBAR VERTEBRAL FRACTURE 20 0.0044
191 CUSHINGOID 14 0.0044
192 ENDOTRACHEAL INTUBATION 12 0.0043
193 BONE CYST 4 0.0043
194 EXERCISE TOLERANCE DECREASED 24 0.0042
195 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 199 0.0041
196 RENAL TUBULAR ACIDOSIS 9 0.0041
197 CENTRAL OBESITY 3 0.0041
198 CREATININE RENAL CLEARANCE INCREASED 3 0.0040
199 DILATED CARDIOMYOPATHY 4 0.0040
200 TOOTH EXTRACTION 49 0.0039
201 RENAL MASS 8 0.0039
202 TESTICULAR PAIN 12 0.0038
203 PATHOGEN RESISTANCE 34 0.0037
204 CEREBELLAR SYNDROME 8 0.0036
205 GINGIVAL RECESSION 7 0.0036
206 HYPOPYON 3 0.0036
207 SPINAL COLUMN INJURY 8 0.0036
208 ENZYME LEVEL INCREASED 3 0.0035
209 CERVICAL VERTEBRAL FRACTURE 12 0.0035
210 KIDNEY FIBROSIS 6 0.0035
211 MENINGITIS CRYPTOCOCCAL 6 0.0034
212 RENAL PAIN 36 0.0034
213 NEPHROLITHIASIS 154 0.0034
214 COLOUR BLINDNESS 3 0.0033
215 STERNAL FRACTURE 4 0.0032
216 PULPITIS DENTAL 3 0.0032
217 TESTICULAR SWELLING 4 0.0032
218 MECHANICAL VENTILATION 6 0.0032
219 DRUG DISPENSED TO WRONG PATIENT 3 0.0031
220 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 5 0.0031
221 RENAL COLIC 7 0.0031
222 CYTOMEGALOVIRUS CHORIORETINITIS 6 0.0031
223 LIPIDS INCREASED 6 0.0030
224 FALSE POSITIVE INVESTIGATION RESULT 3 0.0030
225 SPINAL DEFORMITY 5 0.0030
226 FEMORAL NECK FRACTURE 15 0.0029
227 DRUG SCREEN FALSE POSITIVE 8 0.0029
228 RESPIRATORY TRACT IRRITATION 3 0.0029
229 KYPHOSIS 5 0.0028
230 HEPATITIS B 17 0.0028
231 INTERVERTEBRAL DISC DISORDER 12 0.0028
232 ADRENAL INSUFFICIENCY 34 0.0028
233 LUMBAR SPINAL STENOSIS 8 0.0027
234 OPPORTUNISTIC INFECTION 5 0.0027
235 LARYNGEAL CANCER 3 0.0027
236 PELVIC FRACTURE 21 0.0027
237 POST-TRAUMATIC STRESS DISORDER 18 0.0027
238 RENAL DISORDER 124 0.0027
239 SECONDARY ADRENOCORTICAL INSUFFICIENCY 4 0.0026
240 METABOLIC SURGERY 3 0.0026
241 PULSELESS ELECTRICAL ACTIVITY 11 0.0026
242 ASPARTATE AMINOTRANSFERASE ABNORMAL 4 0.0026
243 FEMUR FRACTURE 81 0.0026
244 DRUG RESISTANCE 67 0.0026
245 FOLATE DEFICIENCY 3 0.0026
246 LUMBAR RADICULOPATHY 3 0.0026
247 HYDRONEPHROSIS 19 0.0025
248 DYSSTASIA 74 0.0025
249 DRUG INTERACTION 395 0.0025
250 SKULL FRACTURE 4 0.0025
251 FACET JOINT SYNDROME 8 0.0025
252 VITAMIN D DECREASED 21 0.0025
253 BONE PAIN 143 0.0024
254 HYPERPARATHYROIDISM 5 0.0024
255 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 20 0.0024
256 COMA SCALE ABNORMAL 7 0.0024
257 HYPERPARATHYROIDISM SECONDARY 6 0.0024
258 HYPERAESTHESIA TEETH 3 0.0024
259 CEREBELLAR INFARCTION 4 0.0024
260 GLUCOSE URINE PRESENT 3 0.0024
261 HYPERPHOSPHATAEMIA 5 0.0023
262 GASTRIC BYPASS 5 0.0023
263 IMPAIRED WORK ABILITY 49 0.0023
264 RADICULOPATHY 6 0.0023
265 INTENTIONAL DOSE OMISSION 63 0.0022
266 RENAL ARTERY STENOSIS 3 0.0022
267 NEPHROGENIC ANAEMIA 10 0.0022
268 PRODUCT DISPENSING ERROR 47 0.0022
269 URINARY TRACT OBSTRUCTION 5 0.0021
270 DEPRESSION 479 0.0021
271 NEPHRITIS 7 0.0021
272 TOOTH DISORDER 46 0.0021
273 ADRENOCORTICAL INSUFFICIENCY ACUTE 4 0.0020
274 HYPERTRIGLYCERIDAEMIA 12 0.0020
275 HIP SURGERY 11 0.0020
276 NEPHRECTOMY 3 0.0020
277 RENAL FUNCTION TEST ABNORMAL 9 0.0019
278 KIDNEY INFECTION 38 0.0019
279 RENAL NEOPLASM 4 0.0019
280 METABOLIC SYNDROME 3 0.0018
281 TENOSYNOVITIS 5 0.0018
282 MAJOR DEPRESSION 13 0.0018
283 HYPOPHOSPHATAEMIA 13 0.0018
284 OESOPHAGEAL CANDIDIASIS 7 0.0018
285 NEPHROTIC SYNDROME 12 0.0017
286 MICTURITION DISORDER 6 0.0017
287 THERAPY CHANGE 17 0.0017
288 SPINAL FUSION SURGERY 7 0.0017
289 BRADYKINESIA 10 0.0017
290 ABNORMAL DREAMS 46 0.0017
291 BEHAVIOUR DISORDER 9 0.0017
292 LOSS OF EMPLOYMENT 5 0.0017
293 TREATMENT NONCOMPLIANCE 90 0.0016
294 PNEUMONIA KLEBSIELLA 3 0.0016
295 MYOPATHY 14 0.0016
296 BLOOD CREATININE DECREASED 5 0.0016
297 HYPERLIPIDAEMIA 19 0.0016
298 SPINAL DISORDER 15 0.0016
299 MYELOPATHY 3 0.0016
300 HEPATITIS B REACTIVATION 5 0.0016
301 LOOSE TOOTH 5 0.0016
302 EXOSTOSIS 14 0.0015
303 BRADYPHRENIA 10 0.0015
304 DRUG LEVEL ABOVE THERAPEUTIC 7 0.0015
305 BUNDLE BRANCH BLOCK RIGHT 7 0.0015
306 WALKING AID USER 10 0.0015
307 INTERVERTEBRAL DISC PROTRUSION 33 0.0015
308 ANORECTAL DISORDER 3 0.0015
309 NASAL DISORDER 4 0.0015
310 EJACULATION FAILURE 3 0.0015
311 MYCOBACTERIUM AVIUM COMPLEX INFECTION 4 0.0015
312 CHONDROPATHY 4 0.0015
313 SKIN WRINKLING 4 0.0015
314 DIVERTICULAR PERFORATION 3 0.0015
315 NEPHROPATHY TOXIC 16 0.0014
316 ALANINE AMINOTRANSFERASE ABNORMAL 3 0.0014
317 MOBILITY DECREASED 101 0.0014
318 JOINT INJURY 30 0.0014
319 PERIODONTITIS 3 0.0014
320 OCULAR ICTERUS 6 0.0014
321 HAEMATURIA 47 0.0014
322 BLOOD PHOSPHORUS DECREASED 5 0.0014
323 GLUCOSE TOLERANCE IMPAIRED 8 0.0014
324 NIGHTMARE 46 0.0013
325 HAEMATOCRIT INCREASED 3 0.0013
326 HAEMODYNAMIC INSTABILITY 10 0.0013
327 MASTICATION DISORDER 4 0.0013
328 PANCREATITIS NECROTISING 3 0.0013
329 BLOOD TRIGLYCERIDES INCREASED 23 0.0013
330 GOUT 23 0.0013
331 ABORTION INDUCED 12 0.0013
332 MULTIPLE INJURIES 8 0.0013
333 DRUG LEVEL INCREASED 21 0.0013
334 DRUG SCREEN POSITIVE 10 0.0013
335 RHABDOMYOLYSIS 52 0.0012
336 RENAL CELL CARCINOMA 6 0.0012
337 EATING DISORDER 26 0.0012
338 BIPOLAR DISORDER 13 0.0012
339 PLANTAR FASCIITIS 4 0.0012
340 POTENTIATING DRUG INTERACTION 4 0.0012
341 MUSCLE ATROPHY 15 0.0012
342 DYSLIPIDAEMIA 6 0.0012
343 LACTOSE INTOLERANCE 3 0.0012
344 PRODUCT DISPENSING ISSUE 5 0.0012
345 LEFT VENTRICULAR FAILURE 4 0.0012
346 FOETAL DEATH 6 0.0012
347 DEPRESSION SUICIDAL 4 0.0012
348 POLLAKIURIA 48 0.0011
349 ERYTHEMA NODOSUM 4 0.0011
350 MENISCUS INJURY 7 0.0011
351 SCOLIOSIS 7 0.0011
352 ALCOHOL ABUSE 3 0.0011
353 BLOOD CREATINE PHOSPHOKINASE INCREASED 32 0.0011
354 INABILITY TO AFFORD MEDICATION 11 0.0011
355 SPONDYLITIS 4 0.0011
356 POLYURIA 9 0.0011
357 GAIT DISTURBANCE 210 0.0011
358 UTERINE LEIOMYOMA 8 0.0011
359 KNEE ARTHROPLASTY 23 0.0011
360 FOOD INTOLERANCE 4 0.0011
361 PRODUCT DOSE OMISSION 71 0.0011
362 NECROSIS 6 0.0011
363 HEPATITIS C 13 0.0011
364 YELLOW SKIN 5 0.0011
365 ERECTILE DYSFUNCTION 27 0.0011
366 DRUG DISPENSING ERROR 16 0.0010
367 SKIN ATROPHY 6 0.0010
368 JOINT DISLOCATION 11 0.0010
369 OESOPHAGEAL ULCER 4 0.0010
370 SUSPECTED COUNTERFEIT PRODUCT 4 0.0010
371 WEIGHT INCREASED 226 0.0010
372 METABOLIC ENCEPHALOPATHY 3 0.0010
373 PRODUCT STORAGE ERROR 87 0.0010
374 RHINITIS 8 0.0010
375 VITAMIN B12 DEFICIENCY 4 0.0010
376 HEPATOCELLULAR INJURY 14 0.0010
377 BLOOD CHOLESTEROL INCREASED 46 0.0010
378 INSURANCE ISSUE 15 0.0010
379 PERIPHERAL ISCHAEMIA 4 0.0010
380 ECTOPIC PREGNANCY 3 0.0010
381 PORTAL HYPERTENSION 3 0.0010
382 FEAR 26 0.0010
383 MALABSORPTION 5 0.0010
384 THERAPY CESSATION 49 0.0010
385 PRODUCT USE COMPLAINT 15 0.0010
386 SPINAL PAIN 11 0.0009
387 SHOULDER OPERATION 4 0.0009
388 CHROMATURIA 21 0.0009
389 BONE CANCER 4 0.0009
390 IMMOBILE 4 0.0009
391 ARTHRITIS 72 0.0009
392 DYSPHEMIA 4 0.0009
393 LYMPHOMA 14 0.0009
394 LIGAMENT RUPTURE 4 0.0009
395 WHEELCHAIR USER 4 0.0009
396 WRONG DRUG ADMINISTERED 8 0.0009
397 PNEUMOCYSTIS JIROVECII PNEUMONIA 9 0.0009
398 OSTEOMYELITIS 16 0.0009
399 LOW BIRTH WEIGHT BABY 7 0.0009
400 MYOCARDIAL ISCHAEMIA 10 0.0009
401 SCIATICA 14 0.0009
402 SEXUAL DYSFUNCTION 10 0.0009
403 NEONATAL RESPIRATORY DISTRESS SYNDROME 3 0.0008
404 BLOOD UREA INCREASED 14 0.0008
405 LIVER DISORDER 37 0.0008
406 RENAL TRANSPLANT 3 0.0008
407 BACK INJURY 9 0.0008
408 NOCTURIA 10 0.0008
409 ABORTION SPONTANEOUS 33 0.0008
410 HEPATOMEGALY 8 0.0008
411 PSYCHIATRIC SYMPTOM 6 0.0008
412 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 5 0.0008
413 NERVE INJURY 9 0.0008
414 FACE INJURY 3 0.0008
415 PRODUCT COLOUR ISSUE 4 0.0008
416 OESOPHAGEAL DISORDER 3 0.0008
417 CACHEXIA 4 0.0008
418 LOW DENSITY LIPOPROTEIN INCREASED 6 0.0008
419 POLYDIPSIA 3 0.0008
420 MYOCLONUS 9 0.0008
421 METABOLIC ACIDOSIS 24 0.0007
422 FOETAL EXPOSURE DURING PREGNANCY 61 0.0007
423 CREATININE RENAL CLEARANCE DECREASED 3 0.0007
424 BODY HEIGHT DECREASED 8 0.0007
425 BACK PAIN 172 0.0007
426 GENERAL PHYSICAL CONDITION ABNORMAL 5 0.0007
427 NEUROPATHY PERIPHERAL 70 0.0007
428 DYSURIA 27 0.0007
429 ANAPHYLACTOID REACTION 3 0.0007
430 JOINT EFFUSION 5 0.0007
431 TRANSAMINASES INCREASED 16 0.0007
432 NIGHT SWEATS 23 0.0007
433 ANGIOPATHY 4 0.0007
434 HYPERKALAEMIA 25 0.0007
435 LACTIC ACIDOSIS 23 0.0007
436 BLADDER DISORDER 7 0.0007
437 HEPATIC PAIN 3 0.0007
438 ALCOHOLISM 3 0.0007
439 PYELONEPHRITIS 6 0.0007
440 ATRIOVENTRICULAR BLOCK FIRST DEGREE 3 0.0007
441 METABOLIC DISORDER 4 0.0007
442 TOOTH ABSCESS 7 0.0007
443 GROIN PAIN 6 0.0007
444 URINE ODOUR ABNORMAL 4 0.0007
445 PRODUCT ODOUR ABNORMAL 7 0.0007
446 TOOTHACHE 12 0.0007
447 ARTHRALGIA 275 0.0007
448 FOETAL GROWTH RESTRICTION 4 0.0007
449 HYPOKALAEMIA 30 0.0006
450 PRODUCT DISTRIBUTION ISSUE 6 0.0006
451 MENTAL DISORDER 28 0.0006
452 BLOOD PROLACTIN INCREASED 3 0.0006
453 MUSCULOSKELETAL DISORDER 12 0.0006
454 ULCER 10 0.0006
455 GAIT INABILITY 21 0.0006
456 MATERNAL EXPOSURE DURING PREGNANCY 56 0.0006
457 PANCREATITIS 33 0.0006
458 BLOOD CALCIUM DECREASED 7 0.0006
459 HYPERCHOLESTEROLAEMIA 6 0.0006
460 STENT PLACEMENT 5 0.0006
461 HYPOKINESIA 9 0.0006
462 RASH GENERALISED 16 0.0006
463 HEPATITIS ACUTE 4 0.0006
464 MICTURITION URGENCY 7 0.0006
465 SUICIDE ATTEMPT 37 0.0006
466 ABNORMAL FAECES 5 0.0006
467 PRODUCT PREPARATION ISSUE 4 0.0006
468 NEOPLASM 7 0.0006
469 UNEVALUABLE EVENT 46 0.0006
470 DEPRESSED MOOD 32 0.0006
471 HEPATIC ENZYME ABNORMAL 3 0.0006
472 CORONARY ARTERIAL STENT INSERTION 3 0.0006
473 AMMONIA INCREASED 3 0.0006
474 HELICOBACTER INFECTION 6 0.0006
475 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
476 SLEEP APNOEA SYNDROME 11 0.0006
477 MENTAL STATUS CHANGES 16 0.0006
478 CATATONIA 3 0.0006
479 CARPAL TUNNEL SYNDROME 8 0.0006
480 SPINAL OPERATION 7 0.0006
481 TENDON RUPTURE 7 0.0006
482 SLEEP DISORDER 40 0.0006
483 DIALYSIS 8 0.0006
484 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 19 0.0006
485 ANAL FISTULA 3 0.0006
486 MYOSITIS 5 0.0006
487 LOSS OF LIBIDO 5 0.0006
488 LIVER FUNCTION TEST ABNORMAL 16 0.0005
489 PROSTATIC DISORDER 3 0.0005
490 ACUTE MYOCARDIAL INFARCTION 16 0.0005
491 RASH MACULO-PAPULAR 12 0.0005
492 AMNESIA 35 0.0005
493 HEPATIC STEATOSIS 10 0.0005
494 MYALGIA 91 0.0005
495 FISTULA 6 0.0005
496 HEPATIC ENZYME INCREASED 36 0.0005
497 ACIDOSIS 4 0.0005
498 JOINT RANGE OF MOTION DECREASED 7 0.0005
499 SEROTONIN SYNDROME 10 0.0005
500 DIFFUSE LARGE B-CELL LYMPHOMA 4 0.0005
501 ASTHENIA 194 0.0005
502 NEUROLEPTIC MALIGNANT SYNDROME 6 0.0005
503 DYSPHAGIA 48 0.0005
504 HYPERTENSION 105 0.0005
505 JOINT STIFFNESS 13 0.0005
506 FEEDING DISORDER 10 0.0005
507 SINUS TACHYCARDIA 7 0.0005
508 INTENTIONAL PRODUCT USE ISSUE 43 0.0005
509 MOTOR DYSFUNCTION 5 0.0005
510 PANCREATITIS ACUTE 11 0.0005
511 HYPERAESTHESIA 4 0.0005
512 HEART RATE IRREGULAR 11 0.0005
513 MANIA 8 0.0005
514 ABNORMAL WEIGHT GAIN 6 0.0005
515 JAUNDICE 13 0.0005
516 HYPERBILIRUBINAEMIA 5 0.0005
517 SUICIDAL IDEATION 44 0.0005
518 INSOMNIA 128 0.0005
519 TUBULOINTERSTITIAL NEPHRITIS 9 0.0005
520 NASAL DRYNESS 3 0.0005
521 POISONING 6 0.0005
522 FOLLICULITIS 5 0.0005
523 INFUSION SITE SWELLING 3 0.0005
524 TREATMENT FAILURE 39 0.0005
525 INJURY 33 0.0005
526 ROTATOR CUFF SYNDROME 6 0.0005
527 EXPOSURE DURING PREGNANCY 29 0.0005
528 PRODUCT CONTAINER ISSUE 4 0.0005
529 SKIN HYPERPIGMENTATION 4 0.0005
530 POOR QUALITY SLEEP 10 0.0005
531 MUSCLE STRAIN 4 0.0005
532 ANAEMIA 88 0.0005
533 SEDATION 12 0.0005
534 CORONAVIRUS INFECTION 3 0.0005
535 GYNAECOMASTIA 14 0.0005
536 APPETITE DISORDER 3 0.0005
537 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 4 0.0005
538 PURPURA 4 0.0005
539 PREGNANCY 9 0.0004
540 PRODUCT PHYSICAL ISSUE 9 0.0004
541 TYPE 2 DIABETES MELLITUS 15 0.0004
542 STATUS EPILEPTICUS 5 0.0004
543 UVEITIS 6 0.0004
544 LIMB INJURY 12 0.0004
545 HALLUCINATION, AUDITORY 7 0.0004
546 OPTIC NEURITIS 4 0.0004
547 ABNORMAL LOSS OF WEIGHT 3 0.0004
548 PERIPHERAL COLDNESS 6 0.0004
549 INTENTIONAL OVERDOSE 28 0.0004
550 DRUG DOSE OMISSION 72 0.0004
551 INCREASED TENDENCY TO BRUISE 4 0.0004
552 NERVE COMPRESSION 4 0.0004
553 AUTOIMMUNE HEPATITIS 3 0.0004
554 DISORIENTATION 17 0.0004
555 HEPATIC ENCEPHALOPATHY 4 0.0004
556 FLANK PAIN 4 0.0004
557 FATIGUE 332 0.0004
558 PHOTOSENSITIVITY REACTION 7 0.0004
559 FLATULENCE 24 0.0004
560 BLOOD URINE PRESENT 8 0.0004
561 RENAL CANCER 20 0.0004
562 FEELING JITTERY 8 0.0004
563 LIVER FUNCTION TEST INCREASED 9 0.0004
564 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
565 AFFECT LABILITY 4 0.0004
566 SWELLING FACE 27 0.0004
567 DERMATITIS BULLOUS 3 0.0004
568 ORAL DISORDER 3 0.0004
569 MUSCULOSKELETAL DISCOMFORT 7 0.0004
570 ABDOMINAL DISTENSION 42 0.0004
571 PAROSMIA 3 0.0004
572 DERMATITIS ALLERGIC 5 0.0004
573 DRUG ERUPTION 7 0.0004
574 AORTIC ANEURYSM 3 0.0004
575 HYPOPHAGIA 10 0.0004
576 FOOD ALLERGY 3 0.0004
577 TENDONITIS 6 0.0004
578 APHTHOUS ULCER 3 0.0004
579 VENTRICULAR EXTRASYSTOLES 4 0.0004
580 GASTROOESOPHAGEAL REFLUX DISEASE 31 0.0004
581 PANIC ATTACK 14 0.0004
582 GENERAL PHYSICAL HEALTH DETERIORATION 44 0.0004
583 MUSCULAR WEAKNESS 43 0.0004
584 MOOD SWINGS 12 0.0004
585 MIDDLE INSOMNIA 7 0.0004
586 DISTURBANCE IN ATTENTION 20 0.0004
587 MUSCLE DISORDER 3 0.0004
588 GASTRIC ULCER 7 0.0004
589 PULMONARY EMBOLISM 35 0.0004
590 OESOPHAGITIS 4 0.0004
591 RASH 159 0.0004
592 ACUTE CORONARY SYNDROME 3 0.0004
593 FOOT DEFORMITY 4 0.0004
594 HYPOAESTHESIA 54 0.0004
595 LIVE BIRTH 3 0.0004
596 ROAD TRAFFIC ACCIDENT 15 0.0004
597 CRYING 13 0.0004
598 HAEMODIALYSIS 3 0.0004
599 PRODUCT USE ISSUE 67 0.0004
600 BLOOD TEST ABNORMAL 5 0.0004
601 DYSPEPSIA 35 0.0004
602 SKIN REACTION 5 0.0004
603 PERIPHERAL SWELLING 54 0.0004
604 GASTRIC DISORDER 12 0.0003
605 PARALYSIS 5 0.0003
606 HYPERSOMNIA 10 0.0003
607 BLOOD MAGNESIUM DECREASED 3 0.0003
608 ANOSMIA 5 0.0003
609 DYSARTHRIA 13 0.0003
610 LOCAL SWELLING 6 0.0003
611 APATHY 5 0.0003
612 PAIN IN EXTREMITY 101 0.0003
613 SOMNOLENCE 69 0.0003
614 EOSINOPHILIA 6 0.0003
615 MEMORY IMPAIRMENT 47 0.0003
616 ARTHROPATHY 19 0.0003
617 SPLENOMEGALY 4 0.0003
618 DIABETES MELLITUS 26 0.0003
619 GRIP STRENGTH DECREASED 3 0.0003
620 NECK PAIN 19 0.0003
621 URINARY INCONTINENCE 10 0.0003
622 DIARRHOEA 217 0.0003
623 HAEMARTHROSIS 3 0.0003
624 ABDOMINAL DISCOMFORT 56 0.0003
625 HEPATIC FAILURE 10 0.0003
626 HYPERGLYCAEMIA 12 0.0003
627 NO THERAPEUTIC RESPONSE 4 0.0003
628 ACCIDENTAL OVERDOSE 12 0.0003
629 MYOCARDIAL INFARCTION 57 0.0003
630 PHARYNGEAL OEDEMA 5 0.0003
631 SMALL INTESTINAL OBSTRUCTION 4 0.0003
632 EMOTIONAL DISORDER 10 0.0003
633 GASTROINTESTINAL DISORDER 29 0.0003
634 OSTEONECROSIS OF JAW 8 0.0003
635 AGEUSIA 8 0.0003
636 ASPARTATE AMINOTRANSFERASE INCREASED 17 0.0003
637 BRAIN FOG 5 0.0003
638 WEIGHT DECREASED 89 0.0003
639 HALLUCINATION 24 0.0003
640 LEUKAEMIA 3 0.0003
641 PRODUCT PACKAGING ISSUE 3 0.0003
642 VOMITING 148 0.0003
643 OBESITY 5 0.0003
644 CHOLESTASIS 6 0.0003
645 VERTIGO 19 0.0003
646 ERUCTATION 6 0.0003
647 SKIN ULCER 8 0.0003
648 BACK DISORDER 5 0.0003
649 RESPIRATORY TRACT INFECTION 8 0.0003
650 MEDICATION ERROR 17 0.0003
651 PARAESTHESIA 48 0.0003
652 LABORATORY TEST ABNORMAL 9 0.0003
653 PSYCHOTIC DISORDER 9 0.0003
654 BEDRIDDEN 4 0.0003
655 ORAL CANDIDIASIS 4 0.0003
656 MUSCLE TWITCHING 7 0.0003
657 SEIZURE 35 0.0003
658 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
659 CYTOMEGALOVIRUS INFECTION 5 0.0003
660 COAGULOPATHY 5 0.0003
661 BLOOD POTASSIUM DECREASED 9 0.0003
662 SEPTIC SHOCK 13 0.0003
663 BRONCHITIS 22 0.0003
664 ANGER 10 0.0003
665 ALANINE AMINOTRANSFERASE INCREASED 18 0.0003
666 ACUTE HEPATIC FAILURE 4 0.0003
667 DEEP VEIN THROMBOSIS 19 0.0003
668 DYSPNOEA EXERTIONAL 11 0.0003
669 NAUSEA 231 0.0003
670 CENTRAL NERVOUS SYSTEM LESION 4 0.0003
671 MUSCLE SPASMS 53 0.0003
672 MENTAL IMPAIRMENT 7 0.0003
673 NERVOUS SYSTEM DISORDER 9 0.0003
674 NEURALGIA 7 0.0003
675 CEREBRAL INFARCTION 7 0.0003
676 LIVER INJURY 7 0.0003
677 MOUTH ULCERATION 6 0.0003
678 HEAD INJURY 9 0.0003
679 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
680 THIRST 5 0.0003
681 LETHARGY 16 0.0003
682 GLYCOSYLATED HAEMOGLOBIN INCREASED 7 0.0003
683 FAECES DISCOLOURED 6 0.0003
684 HYPERTHYROIDISM 4 0.0003
685 PELVIC PAIN 5 0.0003
686 RESTLESS LEGS SYNDROME 5 0.0003
687 CHOLELITHIASIS 9 0.0003
688 IMPAIRED HEALING 9 0.0003
689 GASTROENTERITIS 4 0.0003
690 LOSS OF CONSCIOUSNESS 35 0.0003
691 CARDIOMYOPATHY 4 0.0003
692 LIP SWELLING 9 0.0003
693 THINKING ABNORMAL 5 0.0003
694 MALNUTRITION 3 0.0003
695 HEPATIC FUNCTION ABNORMAL 10 0.0003
696 RASH PAPULAR 6 0.0003
697 HEPATIC CIRRHOSIS 5 0.0003
698 EYE INFECTION 3 0.0003
699 COLITIS 10 0.0003
700 EPILEPSY 8 0.0003
701 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 53 0.0003
702 TINNITUS 12 0.0003
703 CELLULITIS 13 0.0003
704 ABDOMINAL PAIN UPPER 53 0.0003
705 CARDIAC DISORDER 24 0.0003
706 SWELLING 24 0.0003
707 DRUG-INDUCED LIVER INJURY 8 0.0003
708 LYMPHADENOPATHY 9 0.0003
709 PNEUMOTHORAX 4 0.0003
710 COMA 12 0.0003
711 MIGRAINE 24 0.0003
712 ACCIDENT 3 0.0003
713 ELECTROCARDIOGRAM QT PROLONGED 9 0.0002
714 SYNCOPE 25 0.0002
715 DIABETIC KETOACIDOSIS 6 0.0002
716 LOCALISED INFECTION 6 0.0002
717 PRODUCT ADMINISTRATION ERROR 5 0.0002
718 OEDEMA PERIPHERAL 30 0.0002
719 DISCOMFORT 15 0.0002
720 HEADACHE 154 0.0002
721 ALOPECIA 48 0.0002
722 ANGINA PECTORIS 7 0.0002
723 BALANCE DISORDER 21 0.0002
724 CARDIAC ARREST 20 0.0002
725 ABDOMINAL PAIN 56 0.0002
726 EXPIRED PRODUCT ADMINISTERED 8 0.0002
727 JOINT SWELLING 29 0.0002
728 SKIN DISORDER 8 0.0002
729 URINARY RETENTION 8 0.0002
730 MUSCULOSKELETAL STIFFNESS 21 0.0002
731 DERMATITIS 5 0.0002
732 DIZZINESS 119 0.0002
733 CANDIDA INFECTION 4 0.0002
734 TACHYCARDIA 21 0.0002
735 RETCHING 5 0.0002
736 HEPATITIS 6 0.0002
737 SCAR 4 0.0002
738 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6 0.0002
739 INFUSION SITE PAIN 3 0.0002
740 PARANOIA 4 0.0002
741 PRURITUS GENERALISED 5 0.0002
742 ALTERED STATE OF CONSCIOUSNESS 5 0.0002
743 MUSCULOSKELETAL PAIN 12 0.0002
744 BURNING SENSATION 16 0.0002
745 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
746 HEPATOTOXICITY 5 0.0002
747 MALIGNANT MELANOMA 3 0.0002
748 MOOD ALTERED 6 0.0002
749 GINGIVAL BLEEDING 3 0.0002
750 CORONARY ARTERY OCCLUSION 3 0.0002
751 SKIN LESION 6 0.0002
752 CEREBROVASCULAR ACCIDENT 37 0.0002
753 INTENTIONAL PRODUCT MISUSE 19 0.0002
754 FEELING COLD 6 0.0002
755 HAEMOPTYSIS 6 0.0002
756 COORDINATION ABNORMAL 3 0.0002
757 COGNITIVE DISORDER 10 0.0002
758 TOXICITY TO VARIOUS AGENTS 36 0.0002
759 OVERDOSE 46 0.0002
760 PHOTOPHOBIA 4 0.0002
761 SEASONAL ALLERGY 3 0.0002
762 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
763 DECREASED APPETITE 49 0.0002
764 PYREXIA 73 0.0002
765 PRODUCT DOSE OMISSION ISSUE 62 0.0002
766 ECZEMA 11 0.0002
767 SPEECH DISORDER 11 0.0002
768 NEOPLASM MALIGNANT 14 0.0002
769 IMPAIRED QUALITY OF LIFE 3 0.0002
770 FEELING ABNORMAL 50 0.0002
771 ACUTE RESPIRATORY FAILURE 4 0.0002
772 HERNIA 4 0.0002
773 HAEMORRHOIDS 4 0.0002
774 LUNG DISORDER 10 0.0002
775 ANGIOEDEMA 9 0.0002
776 RASH PRURITIC 11 0.0002
777 DISABILITY 4 0.0002
778 PULMONARY MASS 3 0.0002
779 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
780 THERAPY NON-RESPONDER 9 0.0002
781 RASH MACULAR 7 0.0002
782 PNEUMONIA ASPIRATION 5 0.0002
783 LEUKOPENIA 10 0.0002
784 IRRITABILITY 12 0.0002
785 CARDIAC FAILURE 16 0.0002
786 DRY MOUTH 16 0.0002
787 BONE MARROW FAILURE 4 0.0002
788 LIMB DISCOMFORT 6 0.0002
789 MUSCULOSKELETAL CHEST PAIN 3 0.0002
790 INFLAMMATION 10 0.0002
791 PRODUCT SUBSTITUTION ISSUE 11 0.0002
792 ARRHYTHMIA 9 0.0002
793 HALLUCINATION, VISUAL 4 0.0002
794 ABSCESS 3 0.0002
795 SENSORY DISTURBANCE 3 0.0002
796 MOVEMENT DISORDER 6 0.0002
797 IRRITABLE BOWEL SYNDROME 4 0.0002
798 SKIN CANCER 4 0.0002
799 BLOOD POTASSIUM INCREASED 3 0.0002
800 OEDEMA 10 0.0002
801 HYPERSENSITIVITY 34 0.0002
802 PRURITUS 70 0.0002
803 STAPHYLOCOCCAL INFECTION 6 0.0002
804 RESPIRATORY DISTRESS 5 0.0002
805 DEATH 156 0.0002
806 ILL-DEFINED DISORDER 11 0.0002
807 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
808 BLOOD PRESSURE DECREASED 12 0.0002
809 DIVERTICULITIS 5 0.0002
810 SEPSIS 20 0.0002
811 URTICARIA 30 0.0002
812 FACE OEDEMA 3 0.0002
813 CIRCULATORY COLLAPSE 3 0.0002
814 CHEST DISCOMFORT 18 0.0002
815 ILLNESS 18 0.0002
816 CONFUSIONAL STATE 28 0.0002
817 INFECTION 25 0.0002
818 ACNE 13 0.0002
819 NEUROTOXICITY 3 0.0002
820 DYSPHONIA 10 0.0002
821 NASAL CONGESTION 10 0.0002
822 ASCITES 5 0.0002
823 VISUAL IMPAIRMENT 21 0.0002
824 HEAD DISCOMFORT 3 0.0002
825 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
826 HOSPITALISATION 26 0.0002
827 OCULAR HYPERAEMIA 8 0.0002
828 FALL 56 0.0002
829 ISCHAEMIC STROKE 3 0.0002
830 GALLBLADDER DISORDER 3 0.0002
831 DRUG INEFFECTIVE 221 0.0002
832 APHASIA 5 0.0002
833 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
834 RENAL FAILURE ACUTE 7 0.0002
835 PRESYNCOPE 4 0.0002
836 RESTLESSNESS 6 0.0002
837 INJECTION SITE RASH 5 0.0002
838 HAEMORRHAGE 17 0.0002
839 OROPHARYNGEAL PAIN 15 0.0002
840 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
841 PANCYTOPENIA 9 0.0002
842 BACTERIAL INFECTION 3 0.0002
843 CONSTIPATION 35 0.0002
844 AGGRESSION 8 0.0002
845 HYPONATRAEMIA 9 0.0002
846 CARDIOVASCULAR DISORDER 4 0.0002
847 CYSTITIS 5 0.0002
848 HERPES ZOSTER 9 0.0002
849 CHEST PAIN 29 0.0002
850 HYPOTHYROIDISM 5 0.0002
851 PULMONARY OEDEMA 7 0.0002
852 GLAUCOMA 3 0.0002
853 DRUG INTOLERANCE 15 0.0002
854 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 11 0.0002
855 PNEUMONIA 50 0.0002
856 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
857 CHOKING 3 0.0002
858 PALPITATIONS 18 0.0002
859 ORAL HERPES 3 0.0002
860 MENORRHAGIA 3 0.0002
861 MALAISE 67 0.0002
862 GASTRITIS 4 0.0002
863 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
864 SINUS DISORDER 3 0.0002
865 BLOOD PRESSURE INCREASED 23 0.0002
866 RHEUMATOID ARTHRITIS 17 0.0001
867 BLOOD BILIRUBIN INCREASED 4 0.0001
868 FREQUENT BOWEL MOVEMENTS 4 0.0001
869 DYSKINESIA 6 0.0001
870 BLINDNESS 6 0.0001
871 NEUTROPENIA 20 0.0001
872 PALLOR 4 0.0001
873 CONTUSION 14 0.0001
874 TREMOR 24 0.0001
875 COMPLETED SUICIDE 12 0.0001
876 SKIN EXFOLIATION 12 0.0001
877 PAIN IN JAW 4 0.0001
878 SYSTEMIC LUPUS ERYTHEMATOSUS 5 0.0001
879 THERAPY INTERRUPTED 10 0.0001
880 RECTAL HAEMORRHAGE 6 0.0001
881 VISION BLURRED 19 0.0001
882 PRODUCT PRESCRIBING ISSUE 3 0.0001
883 PROSTATE CANCER 11 0.0001
884 CHILLS 16 0.0001
885 MELAENA 3 0.0001
886 FEBRILE NEUTROPENIA 9 0.0001
887 DEHYDRATION 18 0.0001
888 DYSPNOEA 76 0.0001
889 THROMBOCYTOPENIA 15 0.0001
890 PREMATURE BABY 4 0.0001
891 OFF LABEL USE 116 0.0001
892 HYPERHIDROSIS 17 0.0001
893 FEELING HOT 8 0.0001
894 DRUG ADMINISTRATION ERROR 4 0.0001
895 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
896 PLASMA CELL MYELOMA 5 0.0001
897 SWOLLEN TONGUE 4 0.0001
898 ERYTHEMA 26 0.0001
899 ABNORMAL BEHAVIOUR 5 0.0001
900 COUGH 35 0.0001
901 THROMBOSIS 10 0.0001
902 HYPOGLYCAEMIA 6 0.0001
903 AGITATION 9 0.0001
904 ENCEPHALOPATHY 3 0.0001
905 EYE DISORDER 4 0.0001
906 ABASIA 3 0.0001
907 DYSGEUSIA 9 0.0001
908 HEART RATE INCREASED 12 0.0001
909 VIRAL INFECTION 4 0.0001
910 ABDOMINAL PAIN LOWER 3 0.0001
911 CONDITION AGGRAVATED 36 0.0001
912 HAEMATEMESIS 3 0.0001
913 FLUID RETENTION 6 0.0001
914 BLOOD GLUCOSE INCREASED 22 0.0001
915 ANAPHYLACTIC SHOCK 3 0.0001
916 STOMATITIS 7 0.0001
917 HYPOTENSION 23 0.0001
918 ATRIAL FIBRILLATION 11 0.0001
919 DRY SKIN 15 0.0001
920 COLITIS ULCERATIVE 5 0.0001
921 URINARY TRACT INFECTION 19 0.0001
922 ADVERSE DRUG REACTION 10 0.0001
923 C-REACTIVE PROTEIN INCREASED 4 0.0001
924 RESPIRATORY FAILURE 8 0.0001
925 ADVERSE EVENT 10 0.0001
926 INFLUENZA 12 0.0001
927 DEMENTIA 3 0.0001
928 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
929 RED BLOOD CELL COUNT DECREASED 3 0.0001
930 RASH ERYTHEMATOUS 5 0.0001
931 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
932 PLATELET COUNT DECREASED 11 0.0001
933 LACRIMATION INCREASED 3 0.0001
934 THERAPEUTIC RESPONSE DECREASED 6 0.0001
935 EXTRA DOSE ADMINISTERED 4 0.0001
936 INFLUENZA LIKE ILLNESS 8 0.0001
937 NERVOUSNESS 5 0.0001
938 HOT FLUSH 7 0.0001
939 ANAPHYLACTIC REACTION 5 0.0001
940 FUNGAL INFECTION 3 0.0001
941 INJECTION SITE PRURITUS 6 0.0001
942 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
943 EYE PRURITUS 3 0.0001
944 THROAT IRRITATION 4 0.0001
945 SINUSITIS 9 0.0001
946 SKIN DISCOLOURATION 4 0.0001
947 NASOPHARYNGITIS 16 0.0001
948 COVID-19 15 0.0001
949 SURGERY 5 0.0001
950 HYPOXIA 3 0.0001
951 PRODUCT USE IN UNAPPROVED INDICATION 21 0.0001
952 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
953 DRUG ABUSE 7 0.0001
954 CEREBRAL HAEMORRHAGE 3 0.0001
955 SKIN BURNING SENSATION 6 0.0001
956 INJECTION SITE MASS 3 0.0001
957 DRY EYE 4 0.0001
958 INTESTINAL OBSTRUCTION 3 0.0001
959 FLUSHING 8 0.0001
960 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 14 0.0001
961 RHINORRHOEA 5 0.0001
962 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
963 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
964 CARDIAC FAILURE CONGESTIVE 6 0.0001
965 WHITE BLOOD CELL COUNT DECREASED 8 0.0001
966 NEUTROPHIL COUNT DECREASED 3 0.0001
967 HAEMATOCHEZIA 4 0.0001
968 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
969 BLISTER 4 0.0001
970 OXYGEN SATURATION DECREASED 4 0.0001
971 EYE PAIN 4 0.0001
972 EYE IRRITATION 4 0.0001
973 UNDERDOSE 5 0.0001
974 CATARACT 4 0.0001
975 PLEURAL EFFUSION 4 0.0001
976 DISEASE RECURRENCE 3 0.0001
977 ASTHMA 7 0.0001
978 PRODUCT QUALITY ISSUE 8 0.0001
979 DRUG WITHDRAWAL SYNDROME 5 0.0001
980 BRADYCARDIA 3 0.0001
981 DRUG EFFECT DECREASED 3 0.0001
982 PSORIASIS 7 0.0001
983 HAEMOGLOBIN DECREASED 5 0.0000
984 DISEASE PROGRESSION 5 0.0000
985 INJECTION SITE SWELLING 3 0.0000
986 INJECTION SITE PAIN 12 0.0000
987 NO ADVERSE EVENT 7 0.0000
988 INJECTION SITE BRUISING 3 0.0000
989 INCORRECT DOSE ADMINISTERED 7 0.0000